Clarity to present COBRA and CLARIFY abstracts at two world-leading conferences
Sydney, Australia 28 January 2025 Highlights Two abstracts on Clarity’s diagnostic COBRA and CLARIFY trials with 64Cu-SAR-bisPSMA have been accepted for presentation at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2025. An abstract on the COBRA study has also been selected for presentation at the American Urological Association (AUA) Annual Meeting…